Login

Diplomat Pharmacy, Inc. SEC Filings

Filed On Filing
20 Feb 2020 15-12B
14 Feb 2020 SC 13G/A
14 Feb 2020 SC 13G/A
14 Feb 2020 SC 13G/A
13 Feb 2020 SC 13G/A
12 Feb 2020 MS AMENDMENT
12 Feb 2020 SCHEDULE 13G/A
10 Feb 2020 8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
10 Feb 2020 Form 4: Wolin Benjamin, Director

Disposed of 16,398 shares (Tender Offer) ($65.6K) · Returned 33,259 shares to the issuer ($133K)

10 Feb 2020 Form 4: Tomasello Shawn, Director

Disposed of 11,278 shares (Tender Offer) ($45.1K) · Returned 33,259 shares to the issuer ($133K)

10 Feb 2020 Form 4: Loschinskey Dave, Chief Operating Officer

Disposed of 100,038 shares (Tender Offer) ($400K) · Returned 229,528 shares to the issuer · Disposed of 185,640 Employee Stock Option to Acquire Common Stock (Disposition to Issuer)

10 Feb 2020 Form 4: Klepper Kenneth O, Director

Disposed of 46,903 shares (Tender Offer) ($188K) · Returned 33,259 shares to the issuer ($133K)

10 Feb 2020 Form 4: Hagerman Philip R, Director

Disposed of 17,293,456 shares (Tender Offer) ($69.2M) · Returned 33,259 shares to the issuer ($133K)

10 Feb 2020 Form 4: Griffin Brian T, Director

Disposed of 136,113 shares (Tender Offer) ($544K) · Returned 1,303,805 shares to the issuer · Disposed of 371,549 Employee Stock Option to Acquire Common Stock (Disposition to Issuer)

10 Feb 2020 Form 4: Dreyer David C, Director

Disposed of 19,453 shares (Tender Offer) ($77.8K) · Returned 20,674 shares to the issuer ($82.7K)

10 Feb 2020 Form 4: Davison Daniel Paul, Chief Financial Officer

Returned 243,209 shares to the issuer · Disposed of 87,478 Employee Stock Option to Acquire Common Stock (Disposition to Issuer)

10 Feb 2020 Form 4: Benjamin Regina M., Director

Returned 41,019 shares to the issuer ($164K)

10 Feb 2020 S-8 POS
10 Feb 2020 POSASR
10 Feb 2020 25-NSE

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support